Developing vaccines and therapies for the highly pathogenic Nipah and Hendra viruses

NEXT STORY
Asthma Spacers: Global Industry Insights to 2026 – Inspirease is Gaining Huge Demand Owing to Its Ability to Increase the Distance Between MDI & Mouth
PREV STORY
Aptevo Therapeutics to Present New Preclinical Data for APVO436 and ALG.APV.527 at the American Association for Cancer Research 2019 Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aptose Biosciences to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

SAN DIEGO and TORONTO, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) ...

author_avatar
NASDAQ Market News

CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer Therapies

ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 22, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), ...

author_avatar
NASDAQ Market News

Santa Barbara Chiropractor Advanced Chiropractic Group Offers Chiropractic for Stress Relief

SANTA BARBARA, Calif., Jan. 29, 2017 (GLOBE NEWSWIRE) -- Advanced Chiropractic Group would like to ...

author_avatar
NASDAQ Market News